Tower Cold Chain runs hot after Covid booster
Tower’s Chief Executive Officer, Niall Balfour, sat down with Business Magazine, City AM to discuss the companies growth and success after the COVID-19 Pandemic.
It is 22 years since this multi-award-winning company’s founder John Pring filed his first patent for a reusable container to transport temperature sensitive pharmaceuticals, life-science, and biotech products, and 20 years since the first products were launched.
Much has happened in those two decades: a name change from Kryotrans to Tower Cold Chain, a lot of science, a lot of innovation and their products criss-crossing millions of miles across the globe, all of which has brought this company to a preeminent position in container solutions for the global pharmaceutical industry.
Just weeks into the pandemic that paralysed large parts of the world in 2020, Tower Cold Chain received significant investment from Investec that enabled them to scale at a time when the world was calling.
“That was the kick start because we were able to demonstrate real growth in terms of product, people and infrastructure from the year before and show confidence that ours was a very reliable product that could work everywhere in the world.
“We were growing before Covid-19, but it gave us a boost because we were able, at a critical time, to prove our ability to provide a solution to distributing vaccines safely and efficiently, particularly those which needed to be kept ultra-cold.”
Read the full interview here: https://www.cityam.com/tower-cold-chain-runs-hot-after-covid-booster/
